Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 6 (EIF6) is a highly conserved protein that plays a critical role in both ribosome biogenesis and the regulation of translation in eukaryotic cells[1][3][4]. EIF6 binds specifically to the 60S ribosomal subunit, functioning as an anti-association factor that prevents premature assembly of the 40S and 60S ribosomal subunits into the 80S ribosome[1][2][6]. In the nucleolus, EIF6 is essential for the maturation and export of the 60S pre-ribosomal subunit, whereas in the cytoplasm, it must dissociate from 60S before the ribosome can initiate translation[1][2][3]. The activity of EIF6 is regulated through post-translational modifications such as phosphorylation, with kinases like PKC involved in controlling its release from 60S, a process essential to translation initiation[7]. EIF6 is indispensable for cell growth, highly expressed in proliferative tissues, and required for tissue-specific growth and oncogene-driven transformation[1][3][4]. Disruption of EIF6 levels unbalances ribosome production and translation, with potential implications in cancer biology and metabolic regulation[4][5]. No direct drugs or small-molecule inhibitors are currently established for EIF6, and its essential cellular role limits its targetability, but its critical position in translation control and tumorigenesis has brought it increasing attention as a candidate for cancer research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 6 (EIF6).